AstraZeneca Leads FTSE 100 Winners as Pharma Defies Market Rout

AstraZeneca topped FTSE 100 performers despite Friday's 2% market slump, with the £237bn pharma giant leading a small group of defensive gainers as political risk weighed on cyclicals.

AstraZeneca topped FTSE 100 performers despite Friday's 2% market slump, with the £237bn pharma giant leading a small group of defensive gainers as political risk weighed on cyclicals.

London's FTSE 100 closed down 2% on Friday at 10,165, with mining and banking stocks leading losses as speculation over Andy Burnham's leadership bid rattled markets.